Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease

Tolerogenic dendritic cell (tDC)-based clinical trials for the treatment of autoimmune diseases are now a reality. Clinical trials are currently exploring the effectiveness of tDC to treat autoimmune diseases of type 1 diabetes mellitus, rheumatoid arthritis, multiple sclerosis (MS), and Crohn’s dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Brett Eugene, Garciafigueroa, Yesica, Trucco, Massimo, Giannoukakis, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643419/
https://www.ncbi.nlm.nih.gov/pubmed/29075262
http://dx.doi.org/10.3389/fimmu.2017.01279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643419/
https://www.ncbi.nlm.nih.gov/pubmed/29075262
http://dx.doi.org/10.3389/fimmu.2017.01279

Ejemplares similares